Risks tied to this specific entity.
No issues detected across 7 sources
No issues detected across 1 source
Symrise is pursuing the sale of its Terpenes Business and has impaired Swedencare investments, presenting supply chain portfolio and operational continuity risks.
Symrise reports H1 profit and sales declines while maintaining FY guidance, indicating potential operational stress that may reflect supply chain or demand-related challenges requiring further investigation.
finanznachrichten.de: Symrise H1 Profit , Sales Decline ; Confirms FY Outlook; finanznachrichten.de: Symrise To Buy Floral Concept For Undisclosed Sum; rttnews.com: Symrise To Buy Floral Concept For Undisclosed Sum
GDELTNo issues detected across 2 sources
Top origins: Germany, Spain, Netherlands. Period: 2023-09-01 to 2026-09-01
ImportYeti (US Customs)No issues detected across 1 source
Penalties: $102200. Quarters non-compliant: 3. Programs: CAA, RCRA
Penalties: $499980. Quarters non-compliant: 4. Programs: CAA, CWA, RCRA
Penalties: $7813. Quarters non-compliant: 7. Programs: CAA, CWA, RCRA
Penalties: $0. Quarters non-compliant: 12. Programs: CWA
Penalties: $0. Quarters non-compliant: 12. Programs: CWA
Penalties: $900. Quarters non-compliant: 0. Programs: RCRA
Penalties: $3375. Quarters non-compliant: 0. Programs: RCRA
SYMRISE INC: 0 qtrs non-compliance, $900 penalties; SYMRISE INC: 4 qtrs non-compliance, $102200 penalties; RSYMRISE INC: 6 qtrs non-compliance, $499980 penalties
EPA ECHORisks tied to the location of this facility.
Political stability: 0.59, Rule of law: 1.55, Corruption control: 1.66
World Bank WGI 2023No issues detected across 2 sources
PROMED alert in Germany: viral meningitis
PROMED alert in Germany: influenza